Covista Inc. CVSA
Regular-session close
After hours · Nov 19, 4:00 PM ET
- YTD
- +11.64%
- 1 year
- +20.57%
- Market cap
- 3.84B
- Revenue (ttm)
- 2.00B
- Profit margin
- 12.84%
- EPS (ttm)
- 7.64
- Shares out
- 33.26M
- P/E ratio
- 15.12
- Forward P/E
- 11.43
- YTD return
- +11.64%
- 1-year return
- +20.57%
- Volume
- 393.15K
- Avg volume
- 380.22K
- Open
- 118.71
- Previous close
- 119.81
- Day's range
- 115.40 – 120.14
- 52-week range
- 86.97 – 142.13
- Beta
- 0.66
- Price target
- 159.00 (+37.7%)
- Earnings date
- Jan 27, 2027
Key statistics
- 50-day average
- 124.19
- 200-day average
- 119.93
- Enterprise value
- 4.52B
- PEG ratio
- 0.88
- Price / sales
- 1.92
- Price / book
- 2.73
- Revenue growth
- 10.70%
- Free cash flow
- 329.95M
- Total cash
- 222.22M
- Total debt
- 753.59M
- Return on equity
- 19.30%
- Short % of float
- 11.89%
Fundamental scorecard
16 of 25 checks passed on CVSA’s reported financials
16of 25 checks passed
- Value 3 of 5
- Growth 5 of 5
- Profitability 5 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
- Target (low)
- 140.00
- Target (mean)
- 159.00
- Target (high)
- 175.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Jan 27, 2027
Expected Jan 27, 2027. Consensus EPS estimate 2.18.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 27, 2027 | Dec 30, 2026 | 2.18 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.83 | 2.19 | +0.36 | +19.67% |
| Aug 6, 2026 | Jun 30, 2026 | 1.89 | 2.09 | +0.20 | +10.58% |
| May 7, 2026 | Mar 31, 2026 | 1.73 | 1.98 | +0.25 | +14.45% |
| Jan 28, 2026 | Dec 31, 2025 | 2.19 | 2.43 | +0.24 | +10.96% |
| Oct 30, 2025 | Sep 30, 2025 | 1.58 | 1.75 | +0.17 | +10.76% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | BMO Capital | main | Outperform | Outperform |
| Sep 3, 2026 | Truist Securities | down | Buy | Hold |
| Jun 8, 2026 | Barrington Research | main | Outperform | Outperform |
| May 11, 2026 | Truist Securities | main | Buy | Buy |
| Apr 17, 2026 | Barrington Research | main | Outperform | Outperform |
| Mar 24, 2026 | Truist Securities | init | — | Buy |
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Country
- United States
- Website
- covista.com
News
Covista: 3 Key Takeaways for Long-Term Investors
Here's Why Covista (CVSA) is a Strong Value Stock
After Plunging 14.7% in 4 Weeks, Here's Why the Trend Might Reverse for Covista (CVSA)
Is Covista Inc. (CVSA) Outperforming Other Consumer Discretionary Stocks This Year?
Here's Why Covista (CVSA) is a Strong Growth Stock
Covista: Stronger Results Keep Me Bullish, But Cash Flow Needs To Improve
Covista (CVSA) Beats Q1 Earnings and Revenue Estimates
Covista Inc. (CVSA) Q1 2027 Earnings Call Transcript
Covista Q1 2027 Earnings Call Transcript
Covista Q1 2027 Earnings Call Transcript
Your note
Sign in to keep a note on CVSA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEARD STEPHEN W. | Chief Executive Officer | Stock Award(Grant) | Aug 20, 2026 | 477,464 |
| BECK DOUGLAS G | General Counsel | Stock Award(Grant) | Aug 20, 2026 | 33,394 |
| BETZ MICHAEL | Officer | Stock Award(Grant) | Nov 10, 2026 | 56,109 |
| COX KAREN SUE | Officer | Sale | May 7, 2026 | 31,596 |
| HERRERA MAURICE | Officer | Stock Award(Grant) | Nov 11, 2025 | 20,584 |
| MALAFRONTE MICHAEL W | Director | Stock Gift | Aug 30, 2026 | 136,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.47% | 5,145,039 | 594.25M | Sep 29, 2026 |
| FMR, LLC | 12.89% | 4,287,109 | 495.16M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 6.82% | 2,269,551 | 262.13M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 5.58% | 1,854,999 | 214.25M | Sep 29, 2026 |
| Ariel Investments, LLC | 4.94% | 1,644,167 | 189.90M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.44% | 1,475,517 | 170.42M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.10% | 2,027,211 | 234.14M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.08% | 1,024,506 | 118.33M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.65% | 881,160 | 101.77M | Sep 29, 2026 |
| Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund | 2.38% | 791,884 | 91.46M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.23% | 741,666 | 85.66M | Jun 29, 2026 |
| Ariel Investment Trust-Ariel Fund | 2.11% | 701,877 | 81.07M | Jun 29, 2026 |
